San Antonio Breast Cancer Symposium 2021 - 44th Annual Meeting. Virtual/San Antonio - December 7-10, 2021

IF 0.2 4区医学 Q4 Medicine

Drugs of The Future Pub Date : 2022-01-01 DOI:10.1358/dof.2022.47.4.3421335

P. Sudha

引用次数: 0

Abstract

The 2021 San Antonio Breast Cancer Symposium was run as a hybrid meeting allowing its attendees to participate both in person at the Henry B. Gonzalez Convention Center, San Antonio, Texas, and virtually, taking into consideration the safety of attendees due to the ongoing COVID-19 pandemic. The symposium provided state-of-the-art information on etiology, experimental biology, diagnosis, prevention and treatment of breast cancer, as well as premalignant breast diseases.

查看原文本刊更多论文

圣安东尼奥乳腺癌研讨会2021 -第44届年会。虚拟/圣安东尼奥- 2021年12月7日至10日

2021年圣安东尼奥乳腺癌研讨会是一场混合会议，与会者可以在德克萨斯州圣安东尼奥的亨利·b·冈萨雷斯会议中心亲自参加，也可以考虑到正在进行的COVID-19大流行对与会者的安全性的影响，以虚拟方式参加。研讨会提供了关于乳腺癌病因学、实验生物学、诊断、预防和治疗以及乳腺癌前病变的最新信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drugs of The Future 医学-药学

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions. The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.